PN,30801
SC,0001
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F308A1732627305
OL,3,CPopular diabetes and obesity drugs
OL,4,Calso protect kidneys, study suggests
OL,6,FPopular diabetes and obesity drugs
OL,7,Fcould also help to protect the
OL,8,Fkidneys, a new study has suggested.
OL,10,FThe findings indicate the medications
OL,11,Fmight reduce the risk of kidney
OL,12,Fdeterioration and failure, regardless
OL,13,Fof whether or not somebody has
OL,14,Fdiabetes.
OL,16,FAccording to the research, the
OL,17,Fcombined reduction in the risk of
OL,18,Fkidney failure, worsening kidney
OL,19,Ffunction and death due to kidney
OL,20,Fdisease was 19%.
OL,1,W~k4~sj5j5~s1G                    G1/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,309,300,200,140,000,100
PN,30802
SC,0002
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F308A1732627305
OL,3,CPopular diabetes and obesity drugs
OL,4,Calso protect kidneys, study suggests
OL,6,FCalled GLP-1 receptor agonists, the
OL,7,Fdrugs mimic the action of a hormone
OL,8,Fcalled glucagon-like peptide 1, which
OL,9,Fstimulates insulin production and
OL,10,Flowers blood sugar levels, and were
OL,11,Foriginally developed to treat diabetes.
OL,13,FMore recently, they have emerged as
OL,14,Feffective treatments for obesity,
OL,15,Fslowing digestion, increasing feelings
OL,16,Fof fullness and reducing hunger.
OL,1,W~k4~sj5j5~s1G                    G2/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,309,300,200,140,000,100
PN,30803
SC,0003
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F308A1732627305
OL,3,CPopular diabetes and obesity drugs
OL,4,Calso protect kidneys, study suggests
OL,6,FLead author Professor Sunil Badve,
OL,7,Fprofessorial fellow at The George
OL,8,FInstitute for Global Health and UNSW
OL,9,FSydney, said the study expanded
OL,10,Fcurrent knowledge about the drugs in
OL,11,Fkey areas, including benefits in
OL,12,Fpeople with chronic kidney disease
OL,13,F(CKD), and in people with and without
OL,14,Fdiabetes.
OL,1,W~k4~sj5j5~s1G                    G3/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,309,300,200,140,000,100
PN,30804
SC,0004
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F308A1732627305
OL,3,CPopular diabetes and obesity drugs
OL,4,Calso protect kidneys, study suggests
OL,6,FHe said: "This is the first study to
OL,7,Fshow a clear benefit of GLP-1 receptor
OL,8,Fagonists on kidney failure or end-
OL,9,Fstage kidney disease, suggesting they
OL,10,Fhave a key role in kidney-protective
OL,11,Fand heart-protective treatment for
OL,12,Fpatients with common medical
OL,13,Fconditions like type 2 diabetes,
OL,14,Foverweight or obesity with
OL,15,Fcardiovascular disease, or CKD.
OL,17,F"These results are particularly
OL,18,Fimportant for patients with chronic
OL,19,Fkidney disease.
OL,26,@nD@JOUyD@AOU
OL,1,W~k4~sj5j5~s1G                    G4/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,309,300,200,140,000,100
PN,30805
SC,0005
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F308A1732627305
OL,3,CPopular diabetes and obesity drugs
OL,4,Calso protect kidneys, study suggests
OL,6,F"It is a progressive condition
OL,7,Feventually leading to kidney failure
OL,8,Frequiring dialysis or kidney
OL,9,Ftransplantation, and is associated
OL,10,Fwith premature death, mostly from
OL,11,Fheart disease. It has a significant
OL,12,Fimpact on patients' quality of life
OL,13,Fand incurs substantial healthcare
OL,14,Fcosts."
OL,16,FFor the study, published in The Lancet
OL,17,FDiabetes and Endocrinology,
OL,18,Fresearchers conducted an analysis of
OL,19,F11 large-scale clinical trials of GLP-
OL,20,F1 receptor agonists involving a total
OL,21,Fof 85,373 people.
OL,26,@nD@AOUvD@GO]
OL,1,W~k4~sj5j5~s1G                    G5/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,309,300,200,140,000,100
PN,30806
SC,0006
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F308A1732627305
OL,3,CPopular diabetes and obesity drugs
OL,4,Calso protect kidneys, study suggests
OL,6,FSeven different GLP-1 receptor
OL,7,Fagonists were investigated among the
OL,8,Ftrials, including semaglutide (also
OL,9,Fknown as Ozempic or Wegovy),
OL,10,Fdulaglutide (Trulicity) and
OL,11,Fliraglutide (Victoza).
OL,13,FThe results showed that compared to
OL,14,Fdummy drugs, GLP-1 receptor agonists
OL,15,Freduced the risk of kidney failure by
OL,16,F16% and the worsening of kidney
OL,17,Ffunction by 22%.
OL,1,W~k4~sj5j5~s1G                    G6/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,309,300,200,140,000,100
PN,30807
SC,0007
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F308A1732627305
OL,3,CPopular diabetes and obesity drugs
OL,4,Calso protect kidneys, study suggests
OL,6,FThe analysis also confirmed previous
OL,7,Ffindings that the drugs protect heart
OL,8,Fhealth, with a 14% reduction in the
OL,9,Frisk of cardiovascular death, non-
OL,10,Ffatal heart attack, and non-fatal
OL,11,Fstroke, compared to the dummy drug.
OL,13,FDeath by any cause was 13% lower among
OL,14,Fpatients treated with GLP-1 receptor
OL,15,Fagonists.
OL,1,W~k4~sj5j5~s1G                    G7/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,309,300,200,140,000,100
PN,30808
SC,0008
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F308A1732627305
OL,3,CPopular diabetes and obesity drugs
OL,4,Calso protect kidneys, study suggests
OL,6,FProfessor Vlado Perkovic, professorial
OL,7,Ffellow at The George Institute,
OL,8,FProvost at UNSW Sydney and senior
OL,9,Fauthor on the study, said: "This
OL,10,Fresearch shows that GLP-1 receptor
OL,11,Fagonists could play an important role
OL,12,Fin addressing the global burden of non-
OL,13,Fcommunicable diseases.
OL,15,F"Our study will have a major impact on
OL,16,Fclinical guidelines for the management
OL,17,Fof chronic kidney disease and
OL,18,Fcardiovascular disease in people with
OL,19,Fand without diabetes.
OL,26,@qD@\OUwD@AOU
OL,1,W~k4~sj5j5~s1G                    G8/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,309,300,200,140,000,100
PN,30809
SC,0009
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F308A1732627305
OL,3,CPopular diabetes and obesity drugs
OL,4,Calso protect kidneys, study suggests
OL,6,F"More work is now needed to implement
OL,7,Fthe results of this study into
OL,8,Fclinical practice and improve access
OL,9,Fto GLP-1 receptor agonists to people
OL,10,Fwho will benefit from them."
OL,26,@nD@AOUrD@\O]
OL,1,W~k4~sj5j5~s1G                    G9/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,309,300,200,140,000,100
